Global Human Insulin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Human Insulin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Human Insulin Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Market Segment by Application
1.3.1 Global Human Insulin Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Human Insulin Market Size (2017-2028)
2.1.1 Global Human Insulin Revenue (2017-2028)
2.1.2 Global Human Insulin Sales (2017-2028)
2.2 Global Human Insulin Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Human Insulin Sales by Regions (2017-2022)
2.2.2 Global Human Insulin Revenue by Regions (2017-2022)
2.3 Global Human Insulin Market Size Forecast by Region
2.3.1 Global Human Insulin Sales Forecast by Region (2023-2028)
2.3.2 Global Human Insulin Revenue Forecast by Region (2023-2028)
2.4 Global Top Human Insulin Regions (Countries) Ranking by Market Size
2.5 Human Insulin Market Dynamics
2.5.1 Human Insulin Market Trends
2.5.2 Human Insulin Market Drivers
2.5.3 Human Insulin Market Challenges
2.5.4 Human Insulin Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Human Insulin Manufacturers by Sales (2017-2022)
3.1.1 Global Human Insulin Sales by Manufacturers (2017-2022)
3.1.2 Global Human Insulin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Human Insulin Sales in 2021
3.2 Global Top Manufacturers Human Insulin by Revenue
3.2.1 Global Human Insulin Revenue by Manufacturers (2017-2022)
3.2.2 Top Human Insulin Manufacturers Covered: Ranking by Revenue
3.2.3 Global Human Insulin Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Human Insulin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Insulin as of 2021)
3.4 Global Human Insulin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Human Insulin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Human Insulin Market
3.7 Key Manufacturers Human Insulin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Human Insulin Market Size by Type
4.1 Global Human Insulin Historic Market Review by Type (2017-2022)
4.1.1 Global Human Insulin Sales Market Share by Type (2017-2022)
4.1.2 Global Human Insulin Revenue Market Share by Type (2017-2022)
4.1.3 Human Insulin Price by Type (2017-2022)
4.2 Global Human Insulin Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Human Insulin Sales Forecast by Type (2023-2028)
4.2.2 Global Human Insulin Revenue Forecast by Type (2023-2028)
4.2.3 Human Insulin Price Forecast by Type (2023-2028)
5 Global Human Insulin Market Size by Application
5.1 Global Human Insulin Historic Market Review by Application (2017-2022)
5.1.1 Global Human Insulin Sales Market Share by Application (2017-2022)
5.1.2 Global Human Insulin Revenue Market Share by Application (2017-2022)
5.1.3 Human Insulin Price by Application (2017-2022)
5.2 Global Human Insulin Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Human Insulin Sales Forecast by Application (2023-2028)
5.2.2 Global Human Insulin Revenue Forecast by Application (2023-2028)
5.2.3 Human Insulin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Insulin Sales Breakdown by Company
6.1.1 North America Human Insulin Sales by Company (2017-2022)
6.1.2 North America Human Insulin Revenue by Company (2017-2022)
6.2 North America Human Insulin Market Size by Type
6.2.1 North America Human Insulin Sales by Type (2017-2028)
6.2.2 North America Human Insulin Revenue by Type (2017-2028)
6.3 North America Human Insulin Market Size by Application
6.3.1 North America Human Insulin Sales by Application (2017-2028)
6.3.2 North America Human Insulin Revenue by Application (2017-2028)
6.4 North America Human Insulin Market Size by Country
6.4.1 North America Human Insulin Sales by Country (2017-2028)
6.4.2 North America Human Insulin Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Human Insulin Sales Breakdown by Company
7.1.1 Europe Human Insulin Sales by Company (2017-2022)
7.1.2 Europe Human Insulin Revenue by Company (2017-2022)
7.2 Europe Human Insulin Market Size by Type
7.2.1 Europe Human Insulin Sales by Type (2017-2028)
7.2.2 Europe Human Insulin Revenue by Type (2017-2028)
7.3 Europe Human Insulin Market Size by Application
7.3.1 Europe Human Insulin Sales by Application (2017-2028)
7.3.2 Europe Human Insulin Revenue by Application (2017-2028)
7.4 Europe Human Insulin Market Size by Country
7.4.1 Europe Human Insulin Sales by Country (2017-2028)
7.4.2 Europe Human Insulin Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Insulin Sales Breakdown by Company
8.1.1 Asia Pacific Human Insulin Sales by Company (2017-2022)
8.1.2 Asia Pacific Human Insulin Revenue by Company (2017-2022)
8.2 Asia Pacific Human Insulin Market Size by Type
8.2.1 Asia Pacific Human Insulin Sales by Type (2017-2028)
8.2.2 Asia Pacific Human Insulin Revenue by Type (2017-2028)
8.3 Asia Pacific Human Insulin Market Size by Application
8.3.1 Asia Pacific Human Insulin Sales by Application (2017-2028)
8.3.2 Asia Pacific Human Insulin Revenue by Application (2017-2028)
8.4 Asia Pacific Human Insulin Market Size by Region
8.4.1 Asia Pacific Human Insulin Sales by Region
8.4.2 Asia Pacific Human Insulin Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Human Insulin Sales Breakdown by Company
9.1.1 Latin America Human Insulin Sales by Company (2017-2022)
9.1.2 Latin America Human Insulin Revenue by Company (2017-2022)
9.2 Latin America Human Insulin Market Size by Type
9.2.1 Latin America Human Insulin Sales by Type (2017-2028)
9.2.2 Latin America Human Insulin Revenue by Type (2017-2028)
9.3 Latin America Human Insulin Market Size by Application
9.3.1 Latin America Human Insulin Sales by Application (2017-2028)
9.3.2 Latin America Human Insulin Revenue by Application (2017-2028)
9.4 Latin America Human Insulin Market Size by Country
9.4.1 Latin America Human Insulin Sales by Country (2017-2028)
9.4.2 Latin America Human Insulin Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Insulin Sales Breakdown by Company
10.1.1 Middle East and Africa Human Insulin Sales by Company (2017-2022)
10.1.2 Middle East and Africa Human Insulin Revenue by Company (2017-2022)
10.2 Middle East and Africa Human Insulin Market Size by Type
10.2.1 Middle East and Africa Human Insulin Sales by Type (2017-2028)
10.2.2 Middle East and Africa Human Insulin Revenue by Type (2017-2028)
10.3 Middle East and Africa Human Insulin Market Size by Application
10.3.1 Middle East and Africa Human Insulin Sales by Application (2017-2028)
10.3.2 Middle East and Africa Human Insulin Revenue by Application (2017-2028)
10.4 Middle East and Africa Human Insulin Market Size by Country
10.4.1 Middle East and Africa Human Insulin Sales by Country (2017-2028)
10.4.2 Middle East and Africa Human Insulin Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 B. Braun
11.1.1 B. Braun Corporation Information
11.1.2 B. Braun Overview
11.1.3 B. Braun Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 B. Braun Human Insulin Products and Services
11.1.5 B. Braun Human Insulin SWOT Analysis
11.1.6 B. Braun Recent Developments
11.2 Becton, Dickinson
11.2.1 Becton, Dickinson Corporation Information
11.2.2 Becton, Dickinson Overview
11.2.3 Becton, Dickinson Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Becton, Dickinson Human Insulin Products and Services
11.2.5 Becton, Dickinson Human Insulin SWOT Analysis
11.2.6 Becton, Dickinson Recent Developments
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Overview
11.3.3 Biocon Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Biocon Human Insulin Products and Services
11.3.5 Biocon Human Insulin SWOT Analysis
11.3.6 Biocon Recent Developments
11.4 Biodel
11.4.1 Biodel Corporation Information
11.4.2 Biodel Overview
11.4.3 Biodel Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Biodel Human Insulin Products and Services
11.4.5 Biodel Human Insulin SWOT Analysis
11.4.6 Biodel Recent Developments
11.5 ELI Lilly
11.5.1 ELI Lilly Corporation Information
11.5.2 ELI Lilly Overview
11.5.3 ELI Lilly Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 ELI Lilly Human Insulin Products and Services
11.5.5 ELI Lilly Human Insulin SWOT Analysis
11.5.6 ELI Lilly Recent Developments
11.6 Julphar
11.6.1 Julphar Corporation Information
11.6.2 Julphar Overview
11.6.3 Julphar Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Julphar Human Insulin Products and Services
11.6.5 Julphar Human Insulin SWOT Analysis
11.6.6 Julphar Recent Developments
11.7 NOVO Nordisk
11.7.1 NOVO Nordisk Corporation Information
11.7.2 NOVO Nordisk Overview
11.7.3 NOVO Nordisk Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 NOVO Nordisk Human Insulin Products and Services
11.7.5 NOVO Nordisk Human Insulin SWOT Analysis
11.7.6 NOVO Nordisk Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Sanofi Human Insulin Products and Services
11.8.5 Sanofi Human Insulin SWOT Analysis
11.8.6 Sanofi Recent Developments
11.9 Wockhardt
11.9.1 Wockhardt Corporation Information
11.9.2 Wockhardt Overview
11.9.3 Wockhardt Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Wockhardt Human Insulin Products and Services
11.9.5 Wockhardt Human Insulin SWOT Analysis
11.9.6 Wockhardt Recent Developments
11.10 Ypsomed
11.10.1 Ypsomed Corporation Information
11.10.2 Ypsomed Overview
11.10.3 Ypsomed Human Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Ypsomed Human Insulin Products and Services
11.10.5 Ypsomed Human Insulin SWOT Analysis
11.10.6 Ypsomed Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Insulin Value Chain Analysis
12.2 Human Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Insulin Production Mode & Process
12.4 Human Insulin Sales and Marketing
12.4.1 Human Insulin Sales Channels
12.4.2 Human Insulin Distributors
12.5 Human Insulin Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Human Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Insulin Analogs and Biosimilars
Table 3. Major Manufacturers of Human Insulin Biologics
Table 4. Global Human Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Human Insulin Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Human Insulin Sales by Region (2017-2022) & (K Doses)
Table 7. Global Human Insulin Sales Market Share by Region (2017-2022)
Table 8. Global Human Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Human Insulin Revenue Market Share by Region (2017-2022)
Table 10. Global Human Insulin Sales Forecast by Region (2023-2028) & (K Doses)
Table 11. Global Human Insulin Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Human Insulin Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Human Insulin Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Human Insulin Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Human Insulin Market Trends
Table 16. Human Insulin Market Drivers
Table 17. Human Insulin Market Challenges
Table 18. Human Insulin Market Restraints
Table 19. Global Human Insulin Sales by Manufacturers (2017-2022) & (K Doses)
Table 20. Global Human Insulin Sales Share by Manufacturers (2017-2022)
Table 21. Global Human Insulin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Human Insulin Manufacturers by Revenue (US$ Million) in 2021
Table 23. Human Insulin Revenue Share by Manufacturers (2017-2022)
Table 24. Global Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Insulin as of 2021)
Table 26. Key Manufacturers Human Insulin Average Selling Price (ASP) & (2017-2022) & (USD/Dose)
Table 27. Key Manufacturers Human Insulin Plants/Factories Distribution
Table 28. Key Manufacturers Human Insulin Area Served
Table 29. Date of Key Manufacturers Enter into Human Insulin Market
Table 30. Key Manufacturers Human Insulin Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Human Insulin Sales (K Doses) by Type (2017-2022)
Table 33. Global Human Insulin Sales Share by Type (2017-2022)
Table 34. Global Human Insulin Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Human Insulin Price (K Doses) by Type (2017-2022)
Table 36. Global Human Insulin Sales (K Doses) by Type (2023-2028)
Table 37. Global Human Insulin Sales Share by Type (2023-2028)
Table 38. Global Human Insulin Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Human Insulin Revenue Share by Type (2023-2028)
Table 40. Global Human Insulin Price (K Doses) by Type (2023-2028)
Table 41. Global Human Insulin Sales (K Doses) by Application (2017-2022)
Table 42. Global Human Insulin Sales Share by Application (2017-2022)
Table 43. Global Human Insulin Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Human Insulin Price (K Doses) by Application (2017-2022)
Table 45. Global Human Insulin Sales (K Doses) by Application (2023-2028)
Table 46. Global Human Insulin Sales Share by Application (2023-2028)
Table 47. Global Human Insulin Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Human Insulin Revenue Share by Application (2023-2028)
Table 49. Global Human Insulin Price (K Doses) by Application (2023-2028)
Table 50. North America Human Insulin Sales by Company (2017-2022) & (K Doses)
Table 51. North America Human Insulin Sales Market Share by Company (2017-2022)
Table 52. North America Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Human Insulin Revenue Market Share by Company (2017-2022)
Table 54. North America Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 55. North America Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 56. North America Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 59. North America Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 60. North America Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Human Insulin Sales by Country (2017-2022) & (K Doses)
Table 63. North America Human Insulin Sales by Country (2023-2028) & (K Doses)
Table 64. North America Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Human Insulin Sales by Company (2017-2022) & (K Doses)
Table 67. Europe Human Insulin Sales Market Share by Company (2017-2022)
Table 68. Europe Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Human Insulin Revenue Market Share by Company (2017-2022)
Table 70. Europe Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 71. Europe Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 72. Europe Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 75. Europe Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 76. Europe Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Human Insulin Sales by Country (2017-2022) & (K Doses)
Table 79. Europe Human Insulin Sales by Country (2023-2028) & (K Doses)
Table 80. Europe Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Human Insulin Sales by Company (2017-2022) & (K Doses)
Table 83. Asia Pacific Human Insulin Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Human Insulin Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 87. Asia Pacific Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 88. Asia Pacific Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 91. Asia Pacific Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 92. Asia Pacific Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Human Insulin Sales by Region (2017-2022) & (K Doses)
Table 95. Asia Pacific Human Insulin Sales by Region (2023-2028) & (K Doses)
Table 96. Asia Pacific Human Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Human Insulin Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Human Insulin Sales by Company (2017-2022) & (K Doses)
Table 99. Latin America Human Insulin Sales Market Share by Company (2017-2022)
Table 100. Latin America Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Human Insulin Revenue Market Share by Company (2017-2022)
Table 102. Latin America Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 103. Latin America Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 104. Latin America Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 107. Latin America Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 108. Latin America Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Human Insulin Sales by Country (2017-2022) & (K Doses)
Table 111. Latin America Human Insulin Sales by Country (2023-2028) & (K Doses)
Table 112. Latin America Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Human Insulin Sales by Company (2017-2022) & (K Doses)
Table 115. Middle East and Africa Human Insulin Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Human Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Human Insulin Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Human Insulin Sales by Type (2017-2022) & (K Doses)
Table 119. Middle East and Africa Human Insulin Sales by Type (2023-2028) & (K Doses)
Table 120. Middle East and Africa Human Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Human Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Human Insulin Sales by Application (2017-2022) & (K Doses)
Table 123. Middle East and Africa Human Insulin Sales by Application (2023-2028) & (K Doses)
Table 124. Middle East and Africa Human Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Human Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Human Insulin Sales by Country (2017-2022) & (K Doses)
Table 127. Middle East and Africa Human Insulin Sales by Country (2023-2028) & (K Doses)
Table 128. Middle East and Africa Human Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Human Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 130. B. Braun Corporation Information
Table 131. B. Braun Description and Overview
Table 132. B. Braun Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 133. B. Braun Human Insulin Product and Services
Table 134. B. Braun Human Insulin SWOT Analysis
Table 135. B. Braun Recent Developments
Table 136. Becton, Dickinson Corporation Information
Table 137. Becton, Dickinson Description and Overview
Table 138. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 139. Becton, Dickinson Human Insulin Product and Services
Table 140. Becton, Dickinson Human Insulin SWOT Analysis
Table 141. Becton, Dickinson Recent Developments
Table 142. Biocon Corporation Information
Table 143. Biocon Description and Overview
Table 144. Biocon Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 145. Biocon Human Insulin Product and Services
Table 146. Biocon Human Insulin SWOT Analysis
Table 147. Biocon Recent Developments
Table 148. Biodel Corporation Information
Table 149. Biodel Description and Overview
Table 150. Biodel Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 151. Biodel Human Insulin Product and Services
Table 152. Biodel Human Insulin SWOT Analysis
Table 153. Biodel Recent Developments
Table 154. ELI Lilly Corporation Information
Table 155. ELI Lilly Description and Overview
Table 156. ELI Lilly Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 157. ELI Lilly Human Insulin Product and Services
Table 158. ELI Lilly Human Insulin SWOT Analysis
Table 159. ELI Lilly Recent Developments
Table 160. Julphar Corporation Information
Table 161. Julphar Description and Overview
Table 162. Julphar Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 163. Julphar Human Insulin Product and Services
Table 164. Julphar Human Insulin SWOT Analysis
Table 165. Julphar Recent Developments
Table 166. NOVO Nordisk Corporation Information
Table 167. NOVO Nordisk Description and Overview
Table 168. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 169. NOVO Nordisk Human Insulin Product and Services
Table 170. NOVO Nordisk Human Insulin SWOT Analysis
Table 171. NOVO Nordisk Recent Developments
Table 172. Sanofi Corporation Information
Table 173. Sanofi Description and Overview
Table 174. Sanofi Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 175. Sanofi Human Insulin Product and Services
Table 176. Sanofi Human Insulin SWOT Analysis
Table 177. Sanofi Recent Developments
Table 178. Wockhardt Corporation Information
Table 179. Wockhardt Description and Overview
Table 180. Wockhardt Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 181. Wockhardt Human Insulin Product and Services
Table 182. Wockhardt Human Insulin SWOT Analysis
Table 183. Wockhardt Recent Developments
Table 184. Ypsomed Corporation Information
Table 185. Ypsomed Description and Overview
Table 186. Ypsomed Human Insulin Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2017-2022)
Table 187. Ypsomed Human Insulin Product and Services
Table 188. Ypsomed Human Insulin SWOT Analysis
Table 189. Ypsomed Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Human Insulin Distributors List
Table 193. Human Insulin Customers List
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Insulin Product Picture
Figure 2. Global Human Insulin Sales Market Share by Type in 2021 & 2028
Figure 3. Insulin Analogs and Biosimilars Product Picture
Figure 4. Human Insulin Biologics Product Picture
Figure 5. Global Human Insulin Sales Market Share by Application in 2021 & 2028
Figure 6. Short Acting Use Case
Figure 7. Intermediate Acting Use Case
Figure 8. Long Acting Use Case
Figure 9. Pre-Mix Insulin Use Case
Figure 10. Human Insulin Report Years Considered
Figure 11. Global Human Insulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Human Insulin Market Size 2017-2028 (US$ Million)
Figure 13. Global Human Insulin Sales (2017-2022) & (K Doses)
Figure 14. Global Human Insulin Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Human Insulin Sales Market Share by Region (2017-2022)
Figure 16. Global Human Insulin Sales Market Share by Region in 2021
Figure 17. Global Human Insulin Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Human Insulin Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Insulin Sales in 2021
Figure 20. Human Insulin Revenue Share by Manufacturers in 2021
Figure 21. Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Human Insulin Revenue Share by Type (2017-2022)
Figure 23. Global Human Insulin Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Human Insulin Revenue Share by Application (2017-2022)
Figure 25. Global Human Insulin Revenue Growth Rate by Application in 2017 & 2021
Figure 26. North America Human Insulin Sales Market Share by Type (2017-2028)
Figure 27. North America Human Insulin Revenue Market Share by Type (2017-2028)
Figure 28. North America Human Insulin Sales Market Share by Application (2017-2028)
Figure 29. North America Human Insulin Revenue Market Share by Application (2017-2028)
Figure 30. North America Human Insulin Sales Share by Country (2017-2028)
Figure 31. North America Human Insulin Revenue Share by Country (2017-2028)
Figure 32. U.S. Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 33. Canada Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 34. Europe Human Insulin Sales Market Share by Type (2017-2028)
Figure 35. Europe Human Insulin Revenue Market Share by Type (2017-2028)
Figure 36. Europe Human Insulin Sales Market Share by Application (2017-2028)
Figure 37. Europe Human Insulin Revenue Market Share by Application (2017-2028)
Figure 38. Europe Human Insulin Sales Share by Country (2017-2028)
Figure 39. Europe Human Insulin Revenue Share by Country (2017-2028)
Figure 40. Germany Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 41. France Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 42. U.K. Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 43. Italy Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 44. Russia Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 45. Asia Pacific Human Insulin Sales Market Share by Type (2017-2028)
Figure 46. Asia Pacific Human Insulin Revenue Market Share by Type (2017-2028)
Figure 47. Asia Pacific Human Insulin Sales Market Share by Application (2017-2028)
Figure 48. Asia Pacific Human Insulin Revenue Market Share by Application (2017-2028)
Figure 49. Asia Pacific Human Insulin Sales Share by Region (2017-2028)
Figure 50. Asia Pacific Human Insulin Revenue Share by Region (2017-2028)
Figure 51. China Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 52. Japan Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 53. South Korea Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 54. India Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 55. Australia Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 56. Taiwan Human Insulin Revenue (2017-2028) & (US$ Million)
Figure 57. Indonesia Human Insuli

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs